Blue Trust Inc
IMVT icon

Blue Trust Inc’s Immunovant IMVT Stock Holding History

Blue Trust Inc’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08K Hold
32
– – ﹤0.01% 2160
2026
Q2 		$1.23K Hold
32
– – ﹤0.01% 2262
2026
Q1 		$795 Hold
32
– – ﹤0.01% 2290
2025
Q4 		$813 Hold
32
– – ﹤0.01% 2323
2025
Q3 		$516 Hold
32
– – ﹤0.01% 2422
2025
Q2 		$512 Sell
32
-370
-92% -$5.6K ﹤0.01% 2318
2025
Q1 		$6.87K Hold
402
– – ﹤0.01% 2039
2024
Q4 		$10K Buy
402
+318
+379% +$9.02K ﹤0.01% 1873
2024
Q3 		$2.22K Sell
84
-71
-46% -$2.09K ﹤0.01% 2565
2024
Q2 		$5.01K Buy
+155
New +$4.41K ﹤0.01% 2204

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Blue Trust Inc's IMVT Position: Q3 2026 in Review

Blue Trust Inc held its Immunovant (IMVT) position steady in Q3 2026 at 32 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Blue Trust Inc first reported a position in IMVT in Q2 2024 and has held it in 10 quarters since. The position peaked at $10K in Q4 2024. 23 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Blue Trust Inc held 32 shares of Immunovant worth $1.08K as of Q3 2026.
  • Blue Trust Inc left its Immunovant share count unchanged in Q3 2026.
  • Immunovant made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2160 holding.
  • Blue Trust Inc first reported a position in Immunovant in Q2 2024 and has held it in 10 quarters since.
  • Blue Trust Inc's Immunovant position peaked at $10K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.